CD 129 (Ranitidine Hydrochloride 150 mg)
Pill with imprint CD 129 is Brown, Capsule-shape and has been identified as Ranitidine Hydrochloride 150 mg. It is supplied by Dr. Reddy’s Laboratories Inc..
Ranitidine is used in the treatment of gerd; erosive esophagitis; duodenal ulcer; gastric ulcer maintenance treatment; cutaneous mastocytosis (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CD 129
Ranitidine Hydrochloride
- Imprint:
- CD 129
- Strength:
- 150 mg
- Color:
- Brown
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Drug Class:
- H2 antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Dr. Reddy’s Laboratories Inc.
- Inactive Ingredients:
- magnesium stearate
microcrystalline cellulose
sodium starch glycolate type A potato
ferrosoferric oxide
ferric oxide red
ferric oxide yellow
titanium dioxide
gelatin
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 42291-0735 | AvKare, Inc. |
More about ranitidine
- Ranitidine Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 111 Reviews
- Drug class: H2 antagonists
Consumer resources
- Ranitidine
- Ranitidine Injection
- Ranitidine Tablets and Capsules
- Ranitidine Suspension
- Ranitidine Syrup
Other brands: Zantac
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
